Literature DB >> 29150562

The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.

Helen L Wu1, Roger W Wiseman2, Colette M Hughes1, Gabriela M Webb1, Shaheed A Abdulhaqq1, Benjamin N Bimber3, Katherine B Hammond1, Jason S Reed1, Lina Gao3,4, Benjamin J Burwitz1,3, Justin M Greene1, Fidel Ferrer1, Alfred W Legasse3, Michael K Axthelm3, Byung S Park3,5, Simon Brackenridge6, Nicholas J Maness7,8, Andrew J McMichael6, Louis J Picker1,3, David H O'Connor2,9, Scott G Hansen1, Jonah B Sacha10,3.   

Abstract

MHC-E is a highly conserved nonclassical MHC class Ib molecule that predominantly binds and presents MHC class Ia leader sequence-derived peptides for NK cell regulation. However, MHC-E also binds pathogen-derived peptide Ags for presentation to CD8+ T cells. Given this role in adaptive immunity and its highly monomorphic nature in the human population, HLA-E is an attractive target for novel vaccine and immunotherapeutic modalities. Development of HLA-E-targeted therapies will require a physiologically relevant animal model that recapitulates HLA-E-restricted T cell biology. In this study, we investigated MHC-E immunobiology in two common nonhuman primate species, Indian-origin rhesus macaques (RM) and Mauritian-origin cynomolgus macaques (MCM). Compared to humans and MCM, RM expressed a greater number of MHC-E alleles at both the population and individual level. Despite this difference, human, RM, and MCM MHC-E molecules were expressed at similar levels across immune cell subsets, equivalently upregulated by viral pathogens, and bound and presented identical peptides to CD8+ T cells. Indeed, SIV-specific, Mamu-E-restricted CD8+ T cells from RM recognized antigenic peptides presented by all MHC-E molecules tested, including cross-species recognition of human and MCM SIV-infected CD4+ T cells. Thus, MHC-E is functionally conserved among humans, RM, and MCM, and both RM and MCM represent physiologically relevant animal models of HLA-E-restricted T cell immunobiology.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29150562      PMCID: PMC5736429          DOI: 10.4049/jimmunol.1700841

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  78 in total

1.  Two complementary rat NK cell subsets, Ly49s3+ and NKR-P1B+, differ in phenotypic characteristics and responsiveness to cytokines.

Authors:  Lise Kveberg; Pilar Jiménez-Royo; Christian Naper; Bent Rolstad; Geoffrey W Butcher; John T Vaage; Marit Inngjerdingen
Journal:  J Leukoc Biol       Date:  2010-04-15       Impact factor: 4.962

2.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

Review 3.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

4.  The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.

Authors:  V Braud; E Y Jones; A McMichael
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

5.  The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.

Authors:  Jacob Nattermann; Hans Dieter Nischalke; Valeska Hofmeister; Golo Ahlenstiel; Henning Zimmermann; Ludger Leifeld; Elisabeth H Weiss; Tilman Sauerbruch; Ulrich Spengler
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Interferon-gamma induction of the human leukocyte antigen-E gene is mediated through binding of a complex containing STAT1alpha to a distinct interferon-gamma-responsive element.

Authors:  K S Gustafson; G D Ginder
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

7.  Cell surface expression of HLA-E: interaction with human beta2-microglobulin and allelic differences.

Authors:  M Ulbrecht; A Couturier; S Martinozzi; M Pla; R Srivastava; P A Peterson; E H Weiss
Journal:  Eur J Immunol       Date:  1999-02       Impact factor: 5.532

8.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

9.  Immune clearance of highly pathogenic SIV infection.

Authors:  Scott G Hansen; Michael Piatak; Abigail B Ventura; Colette M Hughes; Roxanne M Gilbride; Julia C Ford; Kelli Oswald; Rebecca Shoemaker; Yuan Li; Matthew S Lewis; Awbrey N Gilliam; Guangwu Xu; Nathan Whizin; Benjamin J Burwitz; Shannon L Planer; John M Turner; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Klaus Früh; Jonah B Sacha; Jacob D Estes; Brandon F Keele; Paul T Edlefsen; Jeffrey D Lifson; Louis J Picker
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

10.  The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.

Authors:  Cláudia C Oliveira; Peter A van Veelen; Bianca Querido; Arnoud de Ru; Marjolein Sluijter; Sandra Laban; Jan W Drijfhout; Sjoerd H van der Burg; Rienk Offringa; Thorbald van Hall
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more
  18 in total

1.  MHC-E-Restricted CD8+ T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.

Authors:  Benjamin J Burwitz; Patrick K Hashiguchi; Mandana Mansouri; Christine Meyer; Roxanne M Gilbride; Sreya Biswas; Jennie L Womack; Jason S Reed; Helen L Wu; Michael K Axthelm; Scott G Hansen; Louis J Picker; Klaus Früh; Jonah B Sacha
Journal:  J Immunol       Date:  2020-03-11       Impact factor: 5.422

2.  Vaccine-Mediated Inhibition of the Transporter Associated with Antigen Processing Is Insufficient To Induce Major Histocompatibility Complex E-Restricted CD8+ T Cells in Nonhuman Primates.

Authors:  Shaheed A Abdulhaqq; Helen Wu; John B Schell; Katherine B Hammond; Jason S Reed; Alfred W Legasse; Michael K Axthelm; Byung S Park; Aravind Asokan; Klaus Früh; Scott G Hansen; Louis J Picker; Jonah B Sacha
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

Review 3.  A guide to antigen processing and presentation.

Authors:  Novalia Pishesha; Thibault J Harmand; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2022-04-13       Impact factor: 53.106

4.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

5.  BCL6 Inhibitor-Mediated Downregulation of Phosphorylated SAMHD1 and T Cell Activation Are Associated with Decreased HIV Infection and Reactivation.

Authors:  Yanhui Cai; Mohamed Abdel-Mohsen; Costin Tomescu; Fengtian Xue; Guoxin Wu; Bonnie J Howell; Yong Ai; Jie Sun; Livio Azzoni; Carole Le Coz; Neil Romberg; Luis J Montaner
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor Residues.

Authors:  Paula Ruibal; Kees L M C Franken; Krista E van Meijgaarden; Joeri J F van Loon; Dirk van der Steen; Mirjam H M Heemskerk; Tom H M Ottenhoff; Simone A Joosten
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

7.  Identification of novel HIV-1-derived HLA-E-binding peptides.

Authors:  Zara Hannoun; Zhansong Lin; Simon Brackenridge; Nozomi Kuse; Tomohiro Akahoshi; Nicola Borthwick; Andrew McMichael; Hayato Murakoshi; Masafumi Takiguchi; Tomáš Hanke
Journal:  Immunol Lett       Date:  2018-08-30       Impact factor: 3.685

Review 8.  HLA-E: exploiting pathogen-host interactions for vaccine development.

Authors:  H R Sharpe; G Bowyer; S Brackenridge; T Lambe
Journal:  Clin Exp Immunol       Date:  2019-04-09       Impact factor: 4.330

Review 9.  CD8 + T-cell responses in vaccination: reconsidering targets and function in the context of chronic antigen stimulation.

Authors:  Gabriela Cosma; Laurence Eisenlohr
Journal:  F1000Res       Date:  2018-04-27

10.  Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding.

Authors:  Lucy C Walters; Karl Harlos; Simon Brackenridge; Daniel Rozbesky; Jordan R Barrett; Vitul Jain; Thomas S Walter; Chris A O'Callaghan; Persephone Borrow; Mireille Toebes; Scott G Hansen; Jonah B Sacha; Shaheed Abdulhaqq; Justin M Greene; Klaus Früh; Emily Marshall; Louis J Picker; E Yvonne Jones; Andrew J McMichael; Geraldine M Gillespie
Journal:  Nat Commun       Date:  2018-08-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.